Trial to study effectiveness of new medication on diabetes control
Investigators at Beaumont Hospitals are seeking volunteers with type 2 diabetes  for a research trial to study the effectiveness of a new oral medication called canagliflozin.
“Canagliflozin is an experimental drug that is being tested to see if it may be useful in treating type 2 diabetes,” says Katherine Nori Janosz, M.D. , director of Nutritional Medicine, Beaumont Health Center, Royal Oak and the site’s principal investigator. “We also hope to determine if the drug may reduce the risks that type 2 diabetes poses to the heart and circulatory system.”
According to the National Institutes of Health , type 2 diabetes is the most common form of diabetes, accounting for 90 to 95 percent of all Americans diagnosed with this metabolic disorder.
To be eligible for the study, individuals must:
If a person qualifies, study medication and required examinations, tests, treatments and procedures will be provided at no cost. Study participants will be paid $34 per visit for completing up to 20 office visits. The trial could take up to 8 years.
The Beaumont Research Institute has more than 932 active laboratory and clinical studies involving 81,000 patients that are funded by government, foundation and commercial grants.
# # #